Skip to content

Enterprise value at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Stryker logo
StrykerSYK
$137.35B-12.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$577.67M-23.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$24.74B-12.7%
Globus Medical logo
Globus MedicalGMED
$11.21B+15.6%
Alphatec Holdings logo
Alphatec HoldingsATEC
$2.11B+11.7%

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Calculated from Xtant Medical Holdings’s reported figures.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's enterprise value?
Xtant Medical Holdings (XTNT) reported enterprise value of $80.98M in Q1 2026.
How has Xtant Medical Holdings's enterprise value changed year-over-year?
Xtant Medical Holdings's enterprise value decreased by 2.4% year-over-year, from $82.96M to $80.98M.
What is the long-term trend for Xtant Medical Holdings's enterprise value?
Over 5 years (2020 to 2025), Xtant Medical Holdings's enterprise value has grown at a -1.7% compound annual growth rate (CAGR), from $120.02M to $110.3M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.